COMP <GO>
TWST vs COO // DIVIDEND YIELD & FCF PAYOUT SAFETY
Twist Bioscience Corporation (NASDAQ) VS. The Cooper Companies Inc. (NASDAQ) • 15-METRIC TALLY: TWST 6
— COO 6
■ METRIC PARITY
LAST: $173.45 (0.00%) • MKT CAP: $11.50B
dividend-safety
0.00%
LAST: $60.34 (+1.57%) • MKT CAP: $11.47B
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TWST VS. COO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TWST | COO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 94.20% | 65.50% | +28.70 | TWST | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.70% | 5.30% | -17.00 | COO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 13.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.66% | 3.78% | -4.44 | COO | /fcf-yield <GO> |
| Operating Margin | -4.20% | 16.70% | -20.90 | COO | /operating-margins <GO> |
| Net Profit Margin | -2.40% | 9.20% | -11.60 | COO | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 5.10% | +11.40 | TWST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 3.13 | +22.87 | TWST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | COO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.2 | 55.6 | +1.60 | TWST | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.98 | 1.01 | -0.03 | COO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.0x | 28.5x | -7.50 | TWST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.50B | $11.47B | $26.0M | TWST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TWST REV | COO REV | TWST GROSS % | COO GROSS % | TWST FCF | COO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $4.09B | — | 65.5% | -$75.6M | $433.7M |
| FY 2024 | $0 | $3.90B | — | 66.6% | -$69.2M | $288.1M |
| FY 2023 | $0 | $3.59B | — | — | -$142.5M | $445.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TWST // BETA 0.98
COO // BETA 1.01